Home Spineology Inc

Spineology Inc

One-Year Outcomes Data from the OptiMesh SCOUT Published

“We have found this innovative, minimally invasive device to be a safe and effective option for lumbar interbody fusion procedures,” said SCOUT lead investigator John Chi, M.D., M.P.H. Dr. Chi is the Director of Neurosurgical Oncology at Brigham and Women’s Hospital in Boston, Massachusetts, and Associate Professor of Neurosurgery at Harvard Medical School, and the author of the SPINE article.

OptiMesh Expandable Interbody Fusion System Receives FDA De Novo Grant Reports Spineology

The company is preparing for a Q1 2021 launch of the OptiLIF procedure utilizing the OptiMesh device. This procedure enables enhanced recovery and exceptional efficiency, and its outcomes are supported by prospective FDA IDE clinical data.

Duo™ Angled Instrumentation System Launched by Spineology

The Duo System features the only implant on the market that combines PEEK, titanium, and graft containment mesh elements.

Spineology’s Duo™ Implant: Two Data Presentations

4/16/18: The Duo implant is the first to combine PEEK, titanium, and graft containment mesh elements.

Spineology Receives a Notice of Allowance for a New US Patent on its Duo™ Lumbar Interbody Fusion Implant

3/5/18: Spineology Inc., an innovator in anatomy-conserving spine surgery, is excited to announce it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application No. 15/476,911, “Mesh Spacer Hybrid.”

Spineology® Announces FDA Clearance of Rampart One™ Anterior Lumbar Interbody Fusion System

Spineology, Inc. the innovator in anatomy-conserving surgery™, announced FDA clearance of their Rampart One Anterior Lumbar Interbody...